PharmaVoice Announces 2023 PharmaVoice 100 honorees
PharmaVoice, a leading industry publication covering the most influential voices in the life sciences sector, announced today this year’s class of PharmaVoice 100 honorees.
Now in its 18th year, the PharmaVoice 100 program honors leaders and innovators making significant contributions to the life sciences industry — from molecule to market. These remarkable individuals have demonstrated exceptional dedication, leadership and impact, while helping shape the future of healthcare.
PharmaVoice 100 honorees are selected from a pool of nominations submitted by readers and colleagues, and then evaluated by the PharmaVoice team. They are chosen based on their professional achievements, leadership skills, and their drive to go above and beyond the call of duty to make an impact on their companies, in their communities and for patients. The PharmaVoice 100 list represents a diverse group of professionals from various sectors of the life sciences industry, showcasing the depth and breadth of talent and innovation within the field. This year’s PharmaVoice 100 honorees are divided into nine distinct categories: Standout execs, Trailblazers, Cancer care visionaries, Clinical trial gurus, Patient heroes, Entrepreneurs, Tech wizards, Rare disease warriors, and Brand and commercialization pros.
“This industry is a ground-breaking one capable of changing the world through science and technology. These honorees inspire advancements by guiding their teams, supporting their patients, and propelling their organizations’ missions forward. We are excited to recognize their contributions through this annual list,” said Meagan Parrish, lead editor of PharmaVoice.
The winners will be celebrated during a virtual two-day event PharmaVoice is hosting with its sister publication BioPharma Dive called “The Next Frontier of the Life Sciences” on Oct. 25-26. Hosted by award-winning journalists, this event will feature a range of keynotes, panel discussions and fireside chats on the critical trends facing the industry including innovation, genetic medicine, research hot spots, the biotech market, clinical trial tech advancements and more. The event will wrap up on Thursday Oct. 26 at 3:40p ET with a PharmaVoice 100 celebration where we will salute this year’s honorees and announce the 2023 Red Jacket (the PharmaVoice 100 “hall of fame”) recipients.
For more information about the PharmaVoice 100, the honorees, or the upcoming virtual event, please visit https://www.pharmavoice.com/.
PharmaVoice is a leading industry publication operated by Industry Dive. Our stories deliver the most impactful voices and ideas in the life sciences to industry leaders.
About Industry Dive
Industry Dive, an Informa business, is a leading business journalism company. Over 15 million decision-makers across 20+ competitive industries rely on our exclusive insight and analysis delivered through more than 30 publications.